| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/MRDD.1022 |
| P698 | PubMed publication ID | 11553930 |
| P50 | author | Richard H Myers | Q42418674 |
| P2093 | author name string | M A Nance | |
| P2860 | cites work | Guidelines for the molecular genetics predictive test in Huntington's disease | Q22306172 |
| Transgenic models of Huntington's disease | Q24676606 | ||
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation | Q28246858 | ||
| Huntingtin interacts with a family of WW domain proteins | Q28279245 | ||
| Analysis of a very large trinucleotide repeat in a patient with juvenile Huntington's disease | Q28296368 | ||
| Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice | Q28505664 | ||
| Inactivation of the mouse Huntington's disease gene homolog Hdh | Q28509662 | ||
| Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion | Q28594526 | ||
| Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice | Q29615357 | ||
| Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain | Q29617982 | ||
| Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology | Q33596960 | ||
| A polymorphic DNA marker genetically linked to Huntington's disease | Q34255139 | ||
| Trinucleotide repeat length instability and age of onset in Huntington's disease | Q34357407 | ||
| The neurogenetics genie: testing for the Huntington's disease mutation | Q40624970 | ||
| Presymptomatic testing for Huntington's disease in Wales 1987-90 | Q41107311 | ||
| Factors associated with slow progression in Huntington's disease | Q43593771 | ||
| Mitotic stability and meiotic variability of the (CAG)n repeat in the Huntington disease gene | Q45289840 | ||
| Molecular analysis of juvenile Huntington disease: the major influence on (CAG)n repeat length is the sex of the affected parent. | Q45290342 | ||
| Single sperm analysis of the trinucleotide repeats in the Huntington's disease gene: quantification of the mutation frequency spectrum | Q45291498 | ||
| Genetic testing of children at risk for Huntington's disease. US Huntington Disease Genetic Testing Group | Q45295162 | ||
| Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length | Q45296163 | ||
| Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cDNA. | Q45296558 | ||
| Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease | Q45297318 | ||
| Clinical and neuropathologic assessment of severity in Huntington's disease | Q45298780 | ||
| The expanded CAG repeat associated with juvenile Huntington disease shows a common origin of most or all neurons and glia in human cerebrum. | Q45300454 | ||
| P433 | issue | 3 | |
| P921 | main subject | Huntington's disease | Q190564 |
| P304 | page(s) | 153-157 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Mental Retardation and Developmental Disabilities Research Reviews | Q15764351 |
| P1476 | title | Juvenile onset Huntington's disease--clinical and research perspectives | |
| P478 | volume | 7 |
| Q37718532 | 3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future. |
| Q36993596 | A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington's Disease Gene Mutation. |
| Q33636281 | A case of juvenile huntington disease in a 6-year-old boy |
| Q36628146 | A network dysfunction perspective on neurodegenerative diseases |
| Q92260918 | A soluble truncated tau species related to cognitive dysfunction and caspase-2 is elevated in the brain of Huntington's disease patients |
| Q45305006 | A survey-based study identifies common but unrecognized symptoms in a large series of juvenile Huntington's disease |
| Q57178432 | Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects |
| Q45297647 | Autopsy case of concurrent Huntington's disease and neurofibromatosis type 1. |
| Q45292387 | Better global and cognitive functioning in choreatic versus hypokinetic-rigid Huntington's disease |
| Q64886062 | Brain structure in juvenile-onset Huntington disease. |
| Q45302576 | Case report: concurrent Wilson disease and Huntington disease: lightning can strike twice |
| Q45291809 | Clinical features of Chinese patients with Huntington's disease carrying CAG repeats beyond 60 within HTT gene |
| Q34219730 | Current Pharmacological Management in Juvenile Huntington's Disease. |
| Q90192604 | Diagnosing Juvenile Huntington's Disease: An Explorative Study among Caregivers of Affected Children |
| Q42466838 | Early onset Huntington disease: a neuronal degeneration syndrome |
| Q45295019 | Early onset dystonia and parkinsonism with abnormal globus pallidal signal in MRI: a diagnostic challenge |
| Q45295422 | Early testing for Huntington disease in children: pros and cons |
| Q45303272 | Echogenicity of basal ganglia structures in different Huntington's disease phenotypes |
| Q35088469 | Effectiveness of physiotherapy, occupational therapy, and speech pathology for people with Huntington's disease: a systematic review |
| Q30528756 | Electrophysiological changes precede morphological changes to frontal cortical pyramidal neurons in the rTg4510 mouse model of progressive tauopathy |
| Q40407798 | Examination of Huntington's disease with atypical clinical features in a Bangladeshi family tree |
| Q33632395 | Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs |
| Q37170455 | Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues |
| Q31002975 | Genetically modified pig models for neurodegenerative disorders |
| Q27023050 | Genetics and neuropathology of Huntington's disease |
| Q45290471 | Huntington Disease: Molecular Diagnostics Approach |
| Q42505246 | Huntington disease in a 9-year-old boy: clinical course and neuropathologic examination |
| Q83728053 | Huntington's Disease |
| Q39203917 | Huntington's Disease in Arab Countries |
| Q38689609 | Huntington's Disease: Relationship Between Phenotype and Genotype |
| Q37139113 | Huntington's disease. Part 2: treatment and management issues in juvenile HD. |
| Q41332980 | Intergeneration CAG expansion in a Wuhan juvenile-onset Huntington disease family |
| Q45302239 | Juvenile Huntington disease |
| Q57083854 | Juvenile Huntington disease in an 18-month-old boy revealed by global developmental delay and reduced cerebellar volume |
| Q30498528 | Length polymorphism and head shape association among genes with polyglutamine repeats in the stalk-eyed fly, Teleopsis dalmanni |
| Q40435328 | Long-term monitoring of the mortality trend of Huntington's disease in Austria |
| Q37443153 | Managing juvenile Huntington's disease |
| Q37965763 | Mitochondrial and metabolic-based protective strategies in Huntington's disease: the case of creatine and coenzyme Q. |
| Q37308357 | Mutant huntingtin and mitochondrial dysfunction |
| Q38852106 | Myoclonus epilepsy and ataxia due to KCNC1 mutation: Analysis of 20 cases and K+ channel properties |
| Q35828444 | Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease |
| Q47974512 | Progress in developing transgenic monkey model for Huntington's disease |
| Q89538921 | Prostaglandins as the Agents That Modulate the Course of Brain Disorders |
| Q33936969 | RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model |
| Q45301176 | Stochastic kinetics of intracellular huntingtin aggregate formation. |
| Q37645630 | The Mechanistic Links Between Proteasome Activity, Aging and Age-related Diseases |
| Q37798079 | The clinical and genetic features of Huntington disease |
| Q40828487 | The role of break-induced replication in large-scale expansions of (CAG)n/(CTG)n repeats. |
| Q37778574 | Transcranial Sonography in Huntington’S Disease |
| Q51415889 | Transcriptional regulatory networks underlying gene expression changes in Huntington's disease. |
| Q45289311 | XL PCR for the detection of large trinucleotide expansions in juvenile Huntington's disease |
Search more.